정밀 투여 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 환자 유형별, 툴별, 소프트웨어별, 약물 종류별, 지역별, 경쟁별(2020-2030년)
Precision Dosing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Patient Type, By Tools, By Software, By Drug Class, By Region and Competition, 2020-2030F
상품코드:1878840
리서치사:TechSci Research
발행일:2025년 11월
페이지 정보:영문 185 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 정밀 투여 시장은 2024년에 1억 8,834만 달러로 평가되었으며, 2030년까지 CAGR 7.72%로 성장하여 2억 9,433만 달러에 달할 것으로 예측됩니다.
정밀 투여는 다양한 산업 및 의료 용도에서 미량의 물질을 정확하고 제어된 방식으로 공급하는 기술입니다. 시장 확대를 뒷받침하는 주요 요인으로는 전자제품 제조의 공정 최적화 및 소형화에 대한 수요 증가, 제약 및 생명공학 분야의 엄격한 품질 관리 요건, 다양한 산업 분야의 자동화 기술 보급 확대 등을 꼽을 수 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
1억 8,834만 달러
시장 규모 : 2030년
2억 9,433만 달러
CAGR : 2025-2030년
7.72%
가장 빠르게 성장하는 부문
생리학적 약동학(PBPK) 모델링
최대 시장
북미
주요 시장 촉진요인
주요 시장 과제
주요 시장 동향
목차
제1장 개요
제2장 조사 방법
제3장 주요 요약
제4장 고객의 소리
제5장 세계의 정밀 투여 시장 전망
시장 규모 및 예측
금액별
시장 점유율과 예측
환자 유형별(소아, 노인, 다제 병용 환자, 말초 장기 기능 장애 환자, 기타)
툴별(생리학적 약동학(PBPK) 모델링, 비선형 혼합 효과(NLME) 모델링)
소프트웨어별(웹 기반, 데스크톱 기반)
약물 종류별(항생제, 항진균제, 면역억제제, 항경련제, 항종양제, 항우울제, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 정밀 투여 시장 전망
시장 규모 및 예측
시장 점유율과 예측
북미 : 국가별 분석
미국
캐나다
멕시코
제7장 유럽의 정밀 투여 시장 전망
시장 규모 및 예측
시장 점유율과 예측
유럽 : 국가별 분석
독일
프랑스
영국
이탈리아
스페인
제8장 아시아태평양의 정밀 투여 시장 전망
시장 규모 및 예측
시장 점유율과 예측
아시아태평양 : 국가별 분석
중국
인도
일본
한국
호주
제9장 중동 및 아프리카의 정밀 투여 시장 전망
시장 규모 및 예측
시장 점유율과 예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
남아프리카공화국
제10장 남미의 정밀 투여 시장 전망
시장 규모 및 예측
시장 점유율과 예측
남미 : 국가별 분석
브라질
콜롬비아
아르헨티나
제11장 시장 역학
성장 촉진요인
과제
제12장 시장 동향과 발전
인수합병
제품 출시
최근 동향
제13장 세계의 정밀 투여 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 능력
고객의 능력
대체품의 위협
제15장 경쟁 구도
InsightRX Inc.
Tabula Rasa HealthCare, Inc.
Healthware, Inc.(PrecisePK)
Vesynta Limited
Oxular Limited
Accent Therapeutics, Inc.
Rapport Therapeutics, Inc.
HNP Mikrosysteme GmbH
Fluid-O-Tech Srl
Psycheceutical, Inc.
제16장 전략적 제안
제17장 조사 회사 소개 및 면책사항
KSM
영문 목차
영문목차
The Global Precision Dosing Market, valued at USD 188.34 Million in 2024, is projected to experience a CAGR of 7.72% to reach USD 294.33 Million by 2030. Precision dosing involves the accurate and controlled delivery of substances, often in minute quantities, across diverse industrial and medical applications. Key drivers supporting market expansion include the increasing demand for process optimization and miniaturization in electronics manufacturing, stringent quality control requirements in the pharmaceutical and biotech sectors, and the growing adoption of automation technologies across various industries.
The Global Precision Dosing Market is significantly propelled by advancements in pharmacogenomics and genetic profiling. These scientific developments enable a more profound understanding of individual patient responses to medications by analyzing genetic variations that influence drug metabolism, efficacy, and safety. Such insights are fundamental to tailoring therapeutic regimens with unprecedented accuracy, moving away from generalized treatment protocols. For instance, in an article published in *The Pharmacogenomics Journal*, October 2024, a pharmacogenomics-enriched comprehensive medication management program was associated with 39% fewer inpatient and 39% fewer emergency department visits, highlighting the clinical utility and direct benefits of genetically guided dosing. This precision minimizes adverse drug reactions and optimizes therapeutic outcomes, fostering greater confidence in individualized treatments.
Key Market Challenges
High initial capital expenditure presents a significant impediment to the expansion of the Global Precision Dosing Market. The substantial upfront investment required for advanced precision dosing systems directly limits their adoption, particularly among smaller enterprises or those operating with constrained capital budgets. This financial barrier delays the integration of such technologies, even when their long-term benefits in terms of efficiency and quality are evident.
Key Market Trends
The strategic integration of artificial intelligence and machine learning into dosing protocols is a pivotal trend transforming the Global Precision Dosing Market. These advanced technologies enhance the accuracy and efficiency of drug administration by analyzing vast datasets to predict optimal dosages, identify patient-specific responses, and refine treatment regimens. According to the US Food and Drug Administration's (FDA) Division of Pharmaceutical Manufacturing Assessment III, in a June 2024 address, approximately 40% of companies are already utilizing AI in various capacities within pharmaceutical manufacturing, indicating a significant move towards intelligent systems for production and delivery. This adoption extends to precision dosing, where AI-driven models can continuously learn and adapt, leading to improved therapeutic outcomes.
Key Market Players
InsightRX Inc.
Tabula Rasa HealthCare, Inc.
Healthware, Inc. (PrecisePK)
Vesynta Limited
Oxular Limited
Accent Therapeutics, Inc.
Rapport Therapeutics, Inc.
HNP Mikrosysteme GmbH
Fluid-O-Tech Srl
Psycheceutical, Inc.
Report Scope:
In this report, the Global Precision Dosing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Precision Dosing Market, By Patient Type:
Paediatrics
Geriatrics
Patients on Polypharmacy
Patients with End Organ Dysfunction
Others
Precision Dosing Market, By Tools:
Physiologically Based Pharmacokinetic (PBPK) Modeling
Non-Linear Mixed Effects (NLME) Modeling
Precision Dosing Market, By Software:
Web-Based
Desktop-Based
Precision Dosing Market, By Drug Class:
Antibiotics
Antimycotics
Immunosuppressives
Antiepileptics
Antitumoral Drugs
Antidepressants
Others
Precision Dosing Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies presents in the Global Precision Dosing Market.
Available Customizations:
Global Precision Dosing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Precision Dosing Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Patient Type (Paediatrics, Geriatrics, Patients on Polypharmacy, Patients with End Organ Dysfunction, Others)
5.2.2. By Tools (Physiologically Based Pharmacokinetic (PBPK) Modeling, Non-Linear Mixed Effects (NLME) Modeling)
5.2.3. By Software (Web-Based, Desktop-Based)
5.2.4. By Drug Class (Antibiotics, Antimycotics, Immunosuppressives, Antiepileptics, Antitumoral Drugs, Antidepressants, Others)
5.2.5. By Region
5.2.6. By Company (2024)
5.3. Market Map
6. North America Precision Dosing Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Patient Type
6.2.2. By Tools
6.2.3. By Software
6.2.4. By Drug Class
6.2.5. By Country
6.3. North America: Country Analysis
6.3.1. United States Precision Dosing Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Patient Type
6.3.1.2.2. By Tools
6.3.1.2.3. By Software
6.3.1.2.4. By Drug Class
6.3.2. Canada Precision Dosing Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Patient Type
6.3.2.2.2. By Tools
6.3.2.2.3. By Software
6.3.2.2.4. By Drug Class
6.3.3. Mexico Precision Dosing Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Patient Type
6.3.3.2.2. By Tools
6.3.3.2.3. By Software
6.3.3.2.4. By Drug Class
7. Europe Precision Dosing Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Patient Type
7.2.2. By Tools
7.2.3. By Software
7.2.4. By Drug Class
7.2.5. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Precision Dosing Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Patient Type
7.3.1.2.2. By Tools
7.3.1.2.3. By Software
7.3.1.2.4. By Drug Class
7.3.2. France Precision Dosing Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Patient Type
7.3.2.2.2. By Tools
7.3.2.2.3. By Software
7.3.2.2.4. By Drug Class
7.3.3. United Kingdom Precision Dosing Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Patient Type
7.3.3.2.2. By Tools
7.3.3.2.3. By Software
7.3.3.2.4. By Drug Class
7.3.4. Italy Precision Dosing Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Patient Type
7.3.4.2.2. By Tools
7.3.4.2.3. By Software
7.3.4.2.4. By Drug Class
7.3.5. Spain Precision Dosing Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Patient Type
7.3.5.2.2. By Tools
7.3.5.2.3. By Software
7.3.5.2.4. By Drug Class
8. Asia Pacific Precision Dosing Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Patient Type
8.2.2. By Tools
8.2.3. By Software
8.2.4. By Drug Class
8.2.5. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Precision Dosing Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Patient Type
8.3.1.2.2. By Tools
8.3.1.2.3. By Software
8.3.1.2.4. By Drug Class
8.3.2. India Precision Dosing Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Patient Type
8.3.2.2.2. By Tools
8.3.2.2.3. By Software
8.3.2.2.4. By Drug Class
8.3.3. Japan Precision Dosing Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Patient Type
8.3.3.2.2. By Tools
8.3.3.2.3. By Software
8.3.3.2.4. By Drug Class
8.3.4. South Korea Precision Dosing Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Patient Type
8.3.4.2.2. By Tools
8.3.4.2.3. By Software
8.3.4.2.4. By Drug Class
8.3.5. Australia Precision Dosing Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Patient Type
8.3.5.2.2. By Tools
8.3.5.2.3. By Software
8.3.5.2.4. By Drug Class
9. Middle East & Africa Precision Dosing Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Patient Type
9.2.2. By Tools
9.2.3. By Software
9.2.4. By Drug Class
9.2.5. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Precision Dosing Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Patient Type
9.3.1.2.2. By Tools
9.3.1.2.3. By Software
9.3.1.2.4. By Drug Class
9.3.2. UAE Precision Dosing Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Patient Type
9.3.2.2.2. By Tools
9.3.2.2.3. By Software
9.3.2.2.4. By Drug Class
9.3.3. South Africa Precision Dosing Market Outlook
